631 Development of highly efficacious and safe targeted cancer immunotherapy via IL12-based TMEkine™ platform
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |